96 related articles for article (PubMed ID: 21261509)
1. The atherogenic index of plasma is increased by hormonal contraception.
Soska V; Fiala J; Nebeska K; Jarkovsky J; Hruba D
Scand J Clin Lab Invest; 2011 Apr; 71(2):94-100. PubMed ID: 21261509
[TBL] [Abstract][Full Text] [Related]
2. [Secondary dyslipidaemia after oral contraceptives].
Soska V; Fiala J; Nebeská K; Hrubá D
Vnitr Lek; 2009 Oct; 55(10):929-33. PubMed ID: 19947236
[TBL] [Abstract][Full Text] [Related]
3. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
Bakir R; Hilliquin P
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
Hu P; Lu L; Hu B; Du PF
Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
6. Plasma level of atherogenic and anti-atherogenic factors among palm wine drinkers of rural southwest Nigeria.
Ogunro PS; Ologunagba PO
Afr J Med Med Sci; 2012 Dec; 41(4):337-47. PubMed ID: 23672097
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.
Christodoulakos GE; Lambrinoudaki IV; Economou EV; Papadias C; Panoulis CP; Kouskouni EE; Vlachou SA; Creatsas GC
J Cardiovasc Pharmacol; 2006 Apr; 47(4):542-8. PubMed ID: 16680067
[TBL] [Abstract][Full Text] [Related]
8. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women.
Wu TT; Gao Y; Zheng YY; Ma YT; Xie X
Lipids Health Dis; 2018 Aug; 17(1):197. PubMed ID: 30134981
[TBL] [Abstract][Full Text] [Related]
9. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
11. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
12. [AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice].
Dobiásová M
Vnitr Lek; 2006 Jan; 52(1):64-71. PubMed ID: 16526201
[TBL] [Abstract][Full Text] [Related]
13. Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups.
Bays HE; Shah A; Lin J; Sisk CM; Dong Q; Maccubbin D
Am J Cardiovasc Drugs; 2012 Jun; 12(3):197-206. PubMed ID: 22500948
[TBL] [Abstract][Full Text] [Related]
14. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy].
Dobiásová M; Frohlich J
Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517
[TBL] [Abstract][Full Text] [Related]
15. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
[TBL] [Abstract][Full Text] [Related]
16. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
17. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
18. Lipoproteins status in professional football players after period of vacation and one month after a new intensive training program.
Tater D; Leglise D; Person B; Lambert D; Bercovici JP
Horm Metab Res; 1987 Jan; 19(1):24-7. PubMed ID: 3557279
[TBL] [Abstract][Full Text] [Related]
19. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
20. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
